Literature DB >> 15911861

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Gideon Koren1, Doreen Matsui, Adrienne Einarson, David Knoppert, Meir Steiner.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15911861      PMCID： PMC557982          DOI： 10.1503/cmaj.1041100

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  Risks of untreated depression during pregnancy.

Authors:  Lori Bonari; Heather Bennett; Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2004-01       Impact factor: 3.275

2.  [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

Authors:  R A de Moor; L Mourad; J ter Haar; A C Egberts
Journal:  Ned Tijdschr Geneeskd       Date:  2003-07-12

3.  Neonate characteristics after maternal use of antidepressants in late pregnancy.

Authors:  Bengt Källén
Journal:  Arch Pediatr Adolesc Med       Date:  2004-04

4.  Perinatal outcome following third trimester exposure to paroxetine.

Authors:  Adriana Moldovan Costei; Eran Kozer; Tommy Ho; Shinya Ito; Gideon Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2002-11

5.  Paroxetine levels in postpartum depressed women, breast milk, and infant serum.

Authors:  S Misri; J Kim; K W Riggs; X Kostaras
Journal:  J Clin Psychiatry       Date:  2000-11       Impact factor: 4.384

6.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

7.  Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.

Authors:  Kari Laine; Tuija Heikkinen; Ulla Ekblad; Pentti Kero
Journal:  Arch Gen Psychiatry       Date:  2003-07

Review 8.  Revision of the postpartum depression predictors inventory.

Authors:  Cheryl Tatano Beck
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2002 Jul-Aug

9.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Authors:  Tim F Oberlander; Shaila Misri; Colleen E Fitzgerald; Xanthoula Kostaras; Dan Rurak; Wayne Riggs
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

10.  Birth outcomes after prenatal exposure to antidepressant medication.

Authors:  Victoria Hendrick; Lynne M Smith; Rita Suri; Sun Hwang; Desiree Haynes; Lori Altshuler
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661
View more
  15 in total

1.  Using antidepressants during pregnancy.

Authors:  David Zitner; Angela Bischoff
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

2.  Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2006-05-02       Impact factor: 8.262

3.  Prescribing antidepressants to pregnant women: what is a family physician to do?

Authors:  Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2007-09       Impact factor: 3.275

Review 4.  Depression in childbearing women: when depression complicates pregnancy.

Authors:  Sheila M Marcus; Julie E Heringhausen
Journal:  Prim Care       Date:  2009-03       Impact factor: 2.907

Review 5.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

6.  Clomipramine concentration and withdrawal symptoms in 10 neonates.

Authors:  Peter G J ter Horst; Susanne van der Linde; Jan Pieter Smit; Jan den Boon; Richard A van Lingen; Frank G A Jansman; Lolkje T W De Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 7.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 8.  Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.

Authors:  Maria Muzik; Susan E Hamilton
Journal:  Matern Child Health J       Date:  2016-11

9.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

Review 10.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.